Zeitz
correctly points out an error in my paper.
1 At the same time he takes care to emphasize that the needed correction has no effect on my main conclusion regarding accelerator-produced neutrons. tend to cancel, the averages are better known than it would appear from the data shown and it is probably safe to say that the actual neutron entrance doses for most accelerator models operating above 20 MeV lie within a factor of two of the adopted averages.
The curves of The right-hand column shows that the total integral dose due to accelerator-produced neutrons amounts to about 4-6 g rad per treatment
rad over a wide range of field sizes (we exclude the unavoidable component produced within the patient) and 5 g rad is taken as a nominal value.
When averaged over the entire 70 kg phantom (Table II) , this dose is only 0.36 rad for a 5000 rad treatment course. This surprisingly small result is of course related to the rapid falloff of the neutron dose distribution within tissue.
It is the average dose to the bone marrow that is pertinent to the risk assessment that follows, whereas the 0.36 rad of Table II Table II. * To illustra_tz, as_syme an average fluence per treatment rad of lo5 neutrons cm rad (see Fig. 1 and discussion of p. 3). When multiplied by 5000 rad for the treatment course this gives a fluence of 5 X lo8 neutrons cmm2. Assuming 1 MeV nominal neutron energy, Fig. 8 Based on data published by Rossi and MayslO he has given an estimate of 800 x10 -6 total fatal leukemias per rad developing at any time following a neutron exposure. The mortality from solid tumors is estimated as five times this amount. When combined, the total mortality expected following neutron exposure is estimated as 4.8~ 10 -3 per rad. Ihen multiplied by -9-0.36 rad (from Table II ) we obtain 1.7X10m3 per lifetime. This probability, which greatly exaggerates the risk to the average patient, is appropriate for one young enough that he or she is expected to survive a time corresponding to the latency period of all neutron-induced malignancies.
It is 100 times smaller than the probability of death due to all cancers for the general population, which is 170 x 10 -3 per lifetime.
(The corresponding probability for the limited cohort in question, all members of which already suffer from a malignant condition, is certainly higher than this; the probability of death due to all causes is exactly 1000x lo-3 per lifetime for all members of the general population.)
REGULATORY ACTIONS
A main purpose of the conference was to gather information to enable agencies to formulate regulations regarding this unwanted dose of accelerator-produced neutrons. However, an important point is that this dose is already "regulated" by natural effects; the W-curve of Fig. 1 represents a limit to the fluence that cannot be exceeded except by loss of electron beam before the intended target, or by the use of materials heavier than Pb. This natural limit is about a factor of two above the fluence outside the beam assumed for (6) and Frost and Michel (7) . Rough estimate. 
